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Abstract
Context—Partner services are a broad array of services that should be offered to persons with 
human immunodeficiency virus (HIV) and that are based on a process through which HIV-infected 
persons are interviewed to elicit information about their sex and needle-sharing partners. Human 
immunodeficiency virus testing of partners can result in a high yield of newly diagnosed HIV 
positivity, but despite this yield and the benefits of partners knowing their exposures and HIV 
status, partner services are often not conducted.
Objective—We sought to determine the newly diagnosed HIV positivity and benefits to 2 health 
departments that conducted demonstration projects that focused on statewide HIV partner services.
Design—The main sources of information used for this case study analysis included the health 
department funding applications, progress reports and final reports submitted to the Centers for 
Disease Control and Prevention, and records of communications between Centers for Disease 
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Control and Prevention and the health departments. Required quantitative reporting included the 
number of partners tested and the number of partners with newly diagnosed confirmed HIV 
infection. Required qualitative reporting included how health departments benefited from their 
demonstration project activities.
Setting—Hawaii and New Mexico.
Participants—Sex and needle-sharing partners of persons who were newly diagnosed with HIV 
infection.
Intervention—The use of HIV surveillance data to initiate statewide HIV partner services.
Main Outcome Measure—Newly diagnosed HIV positivity.
Results—During 2012–2015, the newly diagnosed HIV positivity among partners was 18% 
(78/427): 16% (17/108) in Hawaii and 19% (61/319) in New Mexico. The health departments 
benefited from improved collaborations among HIV prevention program and surveillance staff and 
among the health departments, providers, and AIDS service organizations.
Conclusions—Hawaii and New Mexico each achieved a high newly diagnosed HIV positivity 
and benefited from improved local collaborations. As a result of the success of these projects, both 
health departments have continued the activities since the end of category C funding by securing 
alternative funding sources.
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HIV surveillance; newly diagnosed HIV infection; partner services
Partner services are a broad array of services that should be offered to persons with human 
immunodeficiency virus (HIV) and other sexually transmitted diseases (STDs) and that are 
based on a process through which HIV-/STD-infected persons are interviewed to elicit 
information about their sex and needle-sharing partners.1–3 Goals of partner services include 
confidentially notifying partners of their possible exposures and offering early HIV/STD 
testing and other interventions and services, such as HIV pre-exposure prophylaxis for 
partners who test HIV-negative, linkage to HIV medical care for partners who are newly 
diagnosed with HIV, and reengagement to HIV care for partners who are previously 
diagnosed with HIV but currently not in care.1,2,4–7 Human immunodeficiency virus testing 
of partners can yield a newly diagnosed HIV positivity of 6% to 14%,7–11 but despite this 
high yield and the benefits of partners knowing their exposures and HIV status, often partner 
services are not conducted.12,13 Challenges to the successful implementation of partner 
services include state laws and policies that discourage or hinder the ability to conduct 
partner services, patient and community concerns, negative perceptions of partner services 
by prevention and care partners, partners who are anonymous or not otherwise able to be 
located, the workload of staff who are responsible to conduct partner services, and the 
shortage of trained staff.1–3,14,15
The Centers for Disease Control and Prevention (CDC) strongly recommends that all 
persons with newly diagnosed or reported HIV infection receive partner services with active 
health department involvement. Since 2008, the CDC has encouraged health departments to 
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use HIV surveillance data to initiate partner services, but many health departments do not, 
despite improved partner services with the use of HIV surveillance data.12 The main CDC 
Funding Opportunity Announcements for both comprehensive HIV prevention program 
activities (PS12-1201)16 and HIV surveillance case reporting (PS13-1302)17 have allowed 
the use of HIV surveillance data for programmatic purposes since 2012 and 2013, 
respectively. For example, PS12-1201 requirements for routine HIV prevention activities 
include the use of HIV surveillance data such as CD4 and viral load to maximize the number 
of persons identified as candidates for partner services, and PS13-1302 requirements include 
supporting the improvement of health department operations and HIV prevention through 
the sharing of HIV surveillance data. In addition to the aforementioned challenges to 
conducting partner services, the widespread use of HIV surveillance data for partner services 
is limited in jurisdictions with information systems for HIV surveillance and partner services 
that are incompatible.2,14
As part of PS12-1201 funding, health departments were able to compete for additional funds 
to conduct nonresearch demonstration projects known as category C projects. Of the 30 
health departments funded for category C activities, only Hawaii and New Mexico proposed 
and implemented projects that focused on using HIV surveillance data for statewide HIV 
partner services. Hawaii conducted HIV partner services prior to category C funding in 
select publicly funded clinical sites and experienced challenges with private providers and 
community-based organizations that did not participate. Category C funding was an 
opportunity to expand HIV partner services statewide and modernize their activities by using 
surveillance data and integrating HIV and STD partner services. New Mexico health 
department staff who were assigned to regional offices conducted HIV partner services prior 
to category C funding. However, referrals for partner services were primarily from HIV 
testing sites rather than from the use of surveillance data. Category C funding provided an 
opportunity to expand HIV partner services statewide, detect more persons with newly 
diagnosed HIV, and modernize their partner services by using surveillance data.
The main objectives of this article were to determine the newly diagnosed HIV positivity 
based on the use of HIV surveillance data for statewide HIV partner services in Hawaii and 
New Mexico and document lessons learned and how the health departments have benefited 
from using HIV surveillance data for HIV partner services.
Methods
As previously reported, category C was a novel way for CDC to use HIV funds for programs 
and conduct nonresearch demonstration projects by requiring program and scientific staff to 
work closely together at the federal and local levels.18 At CDC, 2 types of staff (project 
officers and scientists) were mainly responsible to work with the health departments. 
Program project officer responsibilities included monitoring adherence to funding 
opportunity announcement requirements and project progress, fiscal oversight, provision of 
programmatic technical assistance, oversight of infrastructure development, and brokerage 
of local partnerships to ensure program and science collaboration. A scientist serving as a 
technical monitor had the responsibility to monitor project results, provide feedback, and 
facilitate any needed technical assistance for epidemiologic, surveillance, cost analysis, or 
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monitoring activities. The CDC determined that each of these projects was a public health 
program activity and thus not human subjects research.
Hawaii
Partner services are permitted under state statute. Health department staff obtained support 
from physicians and the HIV community by providing materials to physicians on the 
rationale of partner services and how they could participate. Physicians and staff from AIDS 
service organizations were also engaged through the formal statewide HIV planning process. 
Health department management developed protocols and a system for HIV surveillance staff 
to share client-level data with HIV prevention program staff in a secure and confidential 
manner19 and then trained staff who were responsible for releasing data from the HIV 
surveillance and laboratory databases and other staff responsible for conducting partner 
services. State HIV surveillance staff provided the names and contact information of all 
persons with newly diagnosed and reported HIV infection (except for persons in the 
military) to health department prevention program staff on a weekly basis. Investigation 
specialists worked with physicians, AIDS service organizations, and HIV case management 
agencies to prioritize and locate these persons for partner services. Initial contact with an 
HIV-infected person could be conducted by a physician, HIV case manager, or an 
investigation specialist. Any information found that was missing in the HIV surveillance 
database (eg, current locating address, HIV risk factor) was shared with HIV surveillance 
staff, who in turn would update the HIV surveillance database.
New Mexico
During the 2010 state legislative session, the state’s HIV Test Act was amended to eliminate 
the legal barrier that prevented persons with newly diagnosed HIV in the HIV surveillance 
database from being referred by HIV surveillance staff specifically for the purpose of 
providing partner services. This legislation was supported by the state’s HIV Prevention 
Community Planning and Action Group and the Governor’s HIV/AIDS Policy Commission. 
The state health department then finalized protocols for partner services. Based on findings 
from a prior survey of providers’ knowledge, attitudes, and barriers related to partner 
services, the health department developed and distributed brochures and referral cards for 
partner services that were tailored to each of the 5 public health regions in the state. The 
health department then sponsored training in partner services and data security and 
confidentiality19 for public health staff throughout the state and led discussions in each 
region to address challenges related to partner services, which included clinician and 
provider resistance to assess client sexual risks and make referrals, particularly for persons 
living with HIV who had new “sentinel risk events” such as a new STD diagnosis. To make 
interviews for partner services most effective, training also focused on motivational 
interviewing and cultural competence. Two epidemiologists from the state HIV and 
Hepatitis Epidemiology Program referred all persons with newly diagnosed and reported 
HIV infection to the Disease Prevention Team in each region where the newly diagnosed and 
reported persons resided. These epidemiologists made referrals by direct data entry of case 
information (eg, name, contact information) into a secure data system. Regional Disease 
Prevention Staff then accessed the information and conducted partner services. In addition, 
the disease prevention staff also conducted HIV partner services for persons living with HIV 
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who were not newly diagnosed. For example, persons living with HIV who had a new 
“sentinel” event that indicated ongoing risk behaviors, such as an STD diagnosis, also 
received HIV partner services.
Data requirements
The main sources of category C information used for this case study analysis included the 
health department funding applications, progress reports, final reports submitted to the CDC, 
and records of communications between the CDC and the health departments, such as e-
mails and meetings. Throughout the 4 years of funding, the health departments submitted to 
the CDC progress reports, which were required every 6 months and included responses to 
standardized quantitative and qualitative questions. In addition, a comprehensive final report 
was submitted to the CDC within 3 months of the end of funding.
For health departments that received category C funds to conduct partner services, required 
quantitative reporting included the number of HIV-infected persons interviewed for partner 
services, the number of named partners, the number of partners tested, and the number of 
partners with newly diagnosed confirmed HIV infection. For all category C health 
departments, required qualitative reporting included lessons learned, how health departments 
benefited from their category C activities, and whether they sustained category C activities 
after the end of category C funding. All health departments were allowed to submit 
additional information, for example, data on HIV viral load suppression, which means that 
the amount of HIV in the blood of an infected person is either undetectable or so low that the 
probability of HIV transmission is reduced by at least 96%.20,21 Hawaii, for example, 
submitted data on viral load suppression and defined it as less than 200 copies per mL.3
Results
During 2012–2015, the 2 health departments interviewed 756 persons who were diagnosed 
and reported with HIV infection (see the Table). These 756 persons named 838 partners. Of 
427 named partners who were tested, the newly diagnosed HIV positivity was 18% (78/427).
Hawaii
In Hawaii during 2013–2015, 311 persons were diagnosed and reported with HIV infection, 
of whom 145 (47%) were interviewed for partner services (see the Table). These 145 
persons named 204 partners. Of 108 named partners who were tested, the newly diagnosed 
HIV positivity was 16% (17/108). Of these 17, 6 moved out of state and 11 were monitored 
with viral load testing; 73% (8/11) achieved viral load suppression.
Hawaii reported 4 main lessons learned specific to partner services. First, relationship 
building with providers and AIDS service organizations was critical (eg, invitations to meet 
with health department staff and participate in the HIV prevention community planning 
process, provision to physicians of written materials that included the rationale for partner 
services and how to participate, and training AIDS service organizations on data security 
and confidentiality),19 which led to their understanding and trust of the process of partner 
services and participation with partner services. Second, the integration of HIV and STD 
partner services and cross-training of HIV and STD staff led to more efficient and timely 
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partner services and less disruption of work when staff turnover occurred. Third, the health 
department changed requirements in its contracts so that local organizations involved with 
partner services understood how best to conduct work related to partners services, which has 
led to improved participation and accountability. Fourth, when providers and other staff who 
are involved with partner services find information that is useful to HIV surveillance staff, 
then that information is entered into the HIV surveillance database, which enhanced the 
quality and timeliness of the surveillance data.
Category C funding helped the health department in 2 main ways. The policy and work that 
started using HIV surveillance data for partner services expanded to include the use of these 
data for engaging out-of-care clients into care (eg, 14 previously HIV-infected persons were 
successfully reengaged to care) and to incorporate HIV pre-exposure prophylaxis into 
partner services (ie, partners who test HIV negative or STD positive are referred to HIV pre-
exposure prophylaxis services). Also, enhanced collaborative relationships occurred among 
the health department, providers, and AIDS service organizations and among prevention, 
treatment and care, and surveillance programs. Since category C funding ended, routine 
PS12-1201 HIV prevention activities and AIDS Drug Assistant Program Rebates are now 
used as alternative funding sources for all category C activities and staff positions.
New Mexico
In New Mexico during 2012–2015, 611 persons were interviewed for partner services, of 
whom 526 were newly diagnosed and reported with HIV (see the Table). These 611 persons 
named 634 partners. Of 319 named partners tested, the newly diagnosed HIV positivity was 
19% (61/319). During the 4 years before category C funding (2008–2011), the newly 
diagnosed positivity was 16% (30/191) among tested partners of HIV-infected persons. 
Results from the category C project also compared favorably in productivity (ie, number of 
new diagnoses found and percentage of tested partners who were newly diagnosed with 
HIV), with 2 pilot projects conducted in New Mexico before category C funding. Using 
routine HIV testing in primary care settings as an HIV case-finding strategy, these 2 pilot 
projects combined identified only 2 new HIV diagnoses among 946 persons tested. Given 
that New Mexico has low/moderate HIV prevalence overall, the Category C strategy for 
partner services was proposed as a more targeted approach to find more newly diagnosed 
persons than prior efforts that used broad-based and nontargeted testing.
As the main lesson learned, New Mexico reported that surveillance-based partner services 
are an important and useful way to initiate partner services. Policies and procedures that 
were created for state epidemiology staff to send information about new HIV diagnoses via a 
secure data system to regional disease prevention staff resulted in a consistent and uniform 
statewide approach to partner services. Direct entry of case information into a secure data 
system was more efficient than calling regional staff, which has led to reduced barriers and 
an increase in the number of successful referrals.
Category C funding helped the health department in 2 main ways. The productivity of HIV 
partner services increased, and enhanced collaborative relationships occurred among 
prevention, HIV medical case management, and surveillance programs. Since category C 
funding ended, Medicaid billing revenue is now used as an alternative funding source to 
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support regional disease prevention team staff to ensure continuity of the category C 
activities.
Discussion
Hawaii and New Mexico conducted demonstration projects that focused on the use of HIV 
surveillance data to initiate HIV partner services, and they each achieved a newly diagnosed 
HIV positivity that was higher than previously reported in the literature.7–11 Because of 
these projects, the health departments benefited from improved collaborations among HIV 
prevention program and surveillance staff and among the health departments, providers, and 
AIDS service organizations. As a result of the success of these projects, both health 
departments have continued the activities since the end of category C funding by securing 
alternative funding sources.
Hawaii and New Mexico have methods and lessons learned that may be useful to other 
health departments, at least to other health departments with a similar capacity to conduct 
this type of work or a similar HIV epidemiologic profile. Both health departments shared 
commonalities in approaches to overcome some of the historic challenges to successful HIV 
partner services. By the time their category C projects started, they had state laws that 
supported partner services, so they then worked to develop policies and protocols for partner 
services, which included the incorporation of CDC guidelines for the security and 
confidentiality of HIV surveillance data.19 Next, they actively engaged providers and AIDS 
service organizations to help them understand the process and importance of partner services 
and included them in the ongoing process of HIV prevention community planning. This 
overcame significant barriers to referrals such as clinician and provider reluctance to assess 
sexual risk histories or refer their patients to the health departments. Finally, they trained all 
staff involved with partner services to ensure confidentiality and effective interviewing for 
partner services.
Hawaii additionally documented that its category C activities resulted in the improved 
quality and timeliness of its surveillance data, which is particularly important in the context 
of the CDC’s recent emphasis on using HIV surveillance data not only for partner services 
but also for other HIV prevention program activities such as linkage and reengagement to 
HIV medical care and monitoring viral load suppression (https://
effectiveinterventions.cdc.gov/en/home.aspx).16 Although Hawaii and New Mexico have 
had complete and timely HIV surveillance data since 2012 and 2013, respectively,22,23 many 
health departments do not,22–24 so when HIV surveillance data are used for linkage and 
reengagement, these activities may not be conducted efficiently or effectively.18,25 By 
increasingly and continually using HIV surveillance data to initiate and monitor HIV 
prevention program activities, staff from both of these disciplines are likely to greatly 
benefit. For example, when program staff work to find and engage out-of-care clients into 
care, they often find information that is critical for HIV surveillance programs (eg, whether 
someone is already in care, current locating information, HIV risk factors), which helps 
make the HIV surveillance data more accurate when data updates are conducted. This in turn 
means that the improved surveillance data when next used for programmatic purposes 
should result in more efficient and effective HIV prevention work.
Beltrami et al. Page 7





















The findings from Hawaii and New Mexico should also influence future research. Partner 
services are a core function of public health,1,16 but little has been published in recent years 
about how best to conduct partner services and their cost-effectiveness.26 This is particularly 
important because federal policy makers, funding agencies, and researchers are increasingly 
emphasizing the HIV continuum of care, which focuses on finding newly diagnosed persons, 
engaging them in HIV medical care, retaining all HIV-infected persons in care, and ensuring 
that they are virally suppressed.27–32 According to a needs assessment in 2008 and a survey 
in 2010, many health departments do not use HIV surveillance data for partner services, 
despite their importance.12,14 With increased emphasis in recent years on using HIV 
surveillance data for partner services, research on partner services that reflects the current 
era of HIV prevention is needed so that relevant up-to-date guidance and capacity building 
support may be provided to health departments and their partners.
Category C work had limitations. First, these demonstration projects did not have a 
standardized protocol across health departments and a more research-oriented methodology 
that would have accounted for various confounding influences and more detailed data 
collection. However, an advantage of the nonresearch category C approach, compared with 
research, is that these projects were conducted in “real-world” settings so that any promising 
or successful methods could be rapidly implemented into routine, daily public health 
practices.18 Furthermore, more extensive data collection would have likely detracted from 
the main purpose of category C funding, which was to provide services to clients and find as 
many new, previously undiagnosed HIV infections as possible. Second, not all persons who 
were newly diagnosed and reported with HIV were interviewed for partner services by 
health departments because these persons were in the military, refused to respond to requests 
for an interview, or were deceased. Third, reporting on 2 health departments that serve 
jurisdictions with lower HIV prevalence and incidence limits the generalizability of the 
results to health departments with higher HIV prevalence and incidence; however, we 
believe that the methods and approaches of Hawaii and New Mexico may still be useful to 
different types of jurisdictions in part because little has been published in recent years on the 
use of HIV surveillance data for partner services.
Conclusion
Human immunodeficiency virus partner services provide a very useful strategy to find 
persons with undiagnosed HIV infection. One main reason is because the work is focused 
directly on persons living with HIV, in contrast to more broad-based and nontargeted 
methods such as routine testing in primary care settings. Partners identified through partner 
services are more likely to have a potential exposure and thus more likely to be infected than 
the population at large.
The results and methods of these 2 demonstration projects have several public health 
implications for the daily practice of HIV partner services. The main results showed the 
success of using HIV surveillance data to find previously undiagnosed persons through HIV 
partner services. The methods can help other health departments that are interested in 
starting or improving their partner services understand the importance of training, having 
program staff help update the HIV surveillance data, and having close working relationships 
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among program and surveillance staff, providers, and community-based organizations. In 
addition, the methods show the importance of focusing on outcomes of partner services (eg, 
confirmed newly diagnosed HIV) and how outcomes can lead to clients receiving other 
services (eg, referring newly and previously diagnosed out-of-care persons to HIV medical 
care services and referring HIV-negative persons for HIV pre-exposure prophylaxis). Finally, 
the CDC’s new emphasis on the use of HIV surveillance data to support the HIV continuum 
of HIV care (https://effectiveinterventions.cdc.gov/en/home.aspx) means that all program 
staff who use HIV surveillance data need to be trained on data security and confidentiality 
requirements.19 By doing so, program staff have the opportunity to actively support HIV 
surveillance programs so that all health departments have the best policies and practices that 
allow for complete, timely, and up-to-date HIV surveillance data. The data may then be used 
for the most efficient and effective HIV prevention activities.
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Implications for Policy & Practice
• The use of HIV surveillance data to initiate HIV partner services is a 
successful strategy to find persons with undiagnosed HIV infection.
• Critical to the success of such a strategy is having program staff help update 
the HIV surveillance data and having close working relationships among 
program and surveillance staff, providers, and community-based 
organizations.
• All program staff who use HIV surveillance data need to be trained on data 
security and confidentiality requirements.
• Focusing on outcomes of partner services (eg, confirmed newly diagnosed 
HIV, previously diagnosed out-of-care persons) may lead to clients receiving 
other prevention and medical services and is important to determine public 
health impact.
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Table
Newly Diagnosed HIV Positivity From Partner Services, Hawaii and New Mexico, 2012–2015
Health Department
No. of Persons 
Interviewed
No. of Named 
Partners No. of Partners Tested
% of Partners With Newly 
Diagnosed HIV
Hawaii 145 204 108 16% (17/108)
New Mexico 611 634 319 19% (61/319)
Total 756 838 427 18% (78/427)
Abbreviation: HIV, human immunodeficiency virus.
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